New Cornell research is providing a fresh view into the ways a common chemotherapy agent, etoposide, stalls and poisons the essential enzymes that allow cancer cells to flourish.
New Delhi [India], January 30 (ANI/NewsVoir): On the occasion of Infusion Nurses Day, BD (Becton, Dickinson, and Company) in partnership with the Infusion Nurses Society (INS) India-US Affiliate organized a series of webinars for Infusion nurses and Infection control nurses across Delhi, Che
A nerve stimulation therapy developed at Columbia University Vagelos College of Physicians and Surgeons is showing promise in animal studies and may eventually allow people with spinal cord injuries to regain the function of their arms.
An approved medication for the treatment of psoriasis is now starting a significant clinical investigation. Patients who have just received a type 1 diabetes diagnosis will test the medication. According to the theory, the medication might maintain the patient's remaining capacity to produce
Hormone Replacement Therapy (HRT) could help prevent Alzheimer's Dementia among women at risk of developing the disease, according to University of East Anglia research.
Chemotherapy and pembrolizumab have been approved for the treatment of women with metastatic, recurring, or persistent cervical cancer whose tumours express PD-L1. Chemotherapy can be administered with or without bevacizumab. Whether pembrolizumab in this combination provides patients with a
New Delhi/Mumbai (Maharashtra) [India], January 24 (ANI/PNN): Amid the ongoing cold waves of winters, smog and air pollution have resumed, thereby increasing the intensity of blocked airways in people's lungs, giving a rise to respiratory problems. But everyone has only one set of lungs, whi
New Delhi [India], January 23 (ANI/BusinessWire India): RoundGlass, a global Wholistic Wellbeing company has identified cutting-edge wellness trends for the year 2023. Wellbeing researchers and experts at RoundGlass dived deep into wellness science research to pick trends that will define ho
Advances in understanding the diverse genetic causes of childhood-onset hearing loss suggest that genomic testing could help with treatment planning, including appropriate therapy timing.
In an effort to treat the rare genetic condition Usher Syndrome Type 2A (USH2A), a University of Houston researcher is developing a gene therapy technique.